|
|
||||||||
|
|
|||||||||
|
|
Oncology-Clinical Diagnosis: Solid TumorsClinical Diagnosis-Solid Tumors Posters |
1 Nuclear Medicine, Catharina Hospital Eindhoven, Eindhoven, Netherlands
1503
Objectives: Earlier, we demonstrated that the heterogeneous distribution of 123I in planar scans of nontoxic, nodular goiters is changed by 0.03 mg rhTSH. Now, using PET-CT, we aimed to quantify and compare the 3D distribution of 18FDG, another interesting metabolic tracer, and 124I within nodular goiters, and to establish their respective levels of stimulation of uptake after rhTSH.
Methods: 10 adult patients, referred for 131I therapy for nontoxic nodular goiter, underwent two PET-CT scans of the cervical region, 1h after administration of 18 MBq 18FDG and 24h after oral administration of 15 MBq 124I. At least 2 wk later, the same scans were repeated 24h after 0.03 mg rhTSH i.m.. After dividing the thyroid into 6x6x6 mm VOIs, Normalized Count Ratios (NCR; comparing
uptake VOI with
uptake entire thyroid; see abstract A. Reijnders) were computed for each VOI. NCR was plotted against %VOI-count for each pairwise comparison. Weighted linear regression analysis was applied to analyze linear trends. Parametric NCR images were produced.
Results: NCR parametric images showed different baseline distributions of 124I and 18FDG and local differences in levels of stimulation of 124I and 18FDG uptake by rhTSH. Three plots of NCR vs %VOI-count showed a negative slope. Baseline 18FDG vs baseline 124I: average slope -0.069 (P<0.02; n=10); stimulated vs baseline 124I: average slope -0.007 (P<0.01; n=10), stimulated vs baseline 18FDG: average slope -0.005 (P<0.03; n=6).
Conclusions: Baseline 124I and 18FDG distribution in nodular goiters differ significantly. rhTSH stimulates 124I and FDG uptake most in areas with low baseline uptake, thereby decreasing the heterogeneity of uptake. Areas with most stimulation by rhTSH in 124I and 18FDG scans do not correspond.
| ||||||||||||||||||||||||||||||||||||||